This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: Innovations of Douglas D McLeod
Introduction
Douglas D McLeod is a notable inventor based in Kingston, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that are useful in treating immune and inflammatory diseases. With a total of 2 patents, his work has garnered attention in the pharmaceutical industry.
Latest Patents
McLeod's latest patents include a process for preparing spiro-hydantoin compounds. This innovative process allows for the preparation of spiro-hydantoin compounds of a specific formula, which are useful in the treatment of various diseases. Additionally, he has developed an asymmetric catalytic hydrogenation process for the preparation of chiral cyclic β-aminoesters. These compounds serve as important intermediates for MMP and TACE inhibitors, showcasing McLeod's expertise in creating valuable pharmaceutical compounds.
Career Highlights
Douglas D McLeod is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to focus on innovative drug development, contributing to advancements in therapeutic solutions.
Collaborations
Throughout his career, McLeod has collaborated with esteemed colleagues, including Albert J DelMonte and T G Murali Dhar. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in the pharmaceutical field.
Conclusion
Douglas D McLeod's contributions to medicinal chemistry and his innovative patents reflect his commitment to advancing healthcare solutions. His work continues to influence the development of new treatments for immune and inflammatory diseases.